Insider Trading: Actavis Inc (ACT)
ACT on New York Consolidated
125.67USD
18 Jun 2013
125.67USD
18 Jun 2013
Price Change (% chg)
$0.73 (+0.58%)
$0.73 (+0.58%)
Prev Close
$124.94
$124.94
Open
$125.22
$125.22
Day's High
$126.27
$126.27
Day's Low
$124.44
$124.44
Volume
621,683
621,683
Avg. Vol
1,602,753
1,602,753
52-wk High
$133.00
$133.00
52-wk Low
$68.57
$68.57
JOYCE ROBERT TODD
| Trading Date | Type | Shares Traded | Price | Shares Held |
|---|---|---|---|---|
| 14 Mar 2013 | Sell | 931 | $91.59 | 98,753 |
| 5 Mar 2013 | Buy | 7,960 | $0.00 | 99,684 |
| 5 Mar 2013 | Buy | 6,716 | $0.00 | 99,684 |
| 4 Mar 2013 | Sell | 1,919 | $86.46 | 85,008 |
| 1 Mar 2013 | Sell | 3,834 | $85.54 | 86,927 |
| 30 Oct 2012 | Buy | 5,817 | $0.00 | 90,761 |
| 31 Jul 2012 | Sell | 4,388 | $78.60 | 84,944 |
| 31 Jul 2012 | Buy | 2,250 | $35.11 | 84,944 |
| 31 Jul 2012 | Sell | 2,612 | $78.60 | 84,944 |
| 31 Jul 2012 | Buy | 574 | $25.64 | 84,944 |
| 31 Jul 2012 | Buy | 4,388 | $38.92 | 84,944 |
| 31 Jul 2012 | Buy | 3,426 | $25.64 | 84,944 |
| 31 Jul 2012 | Sell | 2,250 | $78.60 | 84,944 |
| 31 Jul 2012 | Buy | 2,612 | $38.92 | 84,944 |
| 31 Jul 2012 | Sell | 574 | $78.60 | 84,944 |
| 24 May 2012 | Buy | 5 | $26.40 | 81,518 |
| 13 Mar 2012 | Sell | 1,067 | $59.21 | 81,513 |
| 7 Mar 2012 | Buy | 7,698 | $0.00 | 82,580 |
| 7 Mar 2012 | Buy | 8,356 | $0.00 | 82,580 |
| 23 Feb 2012 | Sell | 1,625 | $58.17 | 66,526 |
| 29 Oct 2011 | Sell | 1,175 | $69.35 | 68,151 |
| 23 Aug 2011 | Sell | 2,924 | $65.46 | 69,326 |
| 23 Aug 2011 | Buy | 4,142 | $26.14 | 69,326 |
| 23 Aug 2011 | Sell | 6,616 | $65.46 | 69,326 |
| 23 Aug 2011 | Buy | 2,141 | $26.40 | 69,326 |
Institutional Holders
| % Shares Owned: | 0.00% |
| # of Holders: | 662 |
| Total Shares Held: | 159,213,407 |
| 3 Mo. Net Change: | 9,615,750 |
| # New Positions: | 67 |
| # Closed Positions: | 89 |
| # Increased Positions: | 282 |
| # Reduced Positions: | 335 |
| # Net Buyers: | -53 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Andrew Turner |
66 | 2008 | Independent Chairman of the Board |
Paul Bisaro |
52 | 2007 | President, Chief Executive Officer, Director |
Sigurdur Olafsson |
44 | 2012 | President - Actavis Pharma |
Robert Stewart |
45 | 2012 | President - Global Operations |
G. Frederick Wilkinson |
56 | 2012 | President - Actavis Specialty Brands |
David Buchen |
48 | 2012 | Chief Legal Officer, Global |
Patrick Eagan |
55 | 2012 | Chief Human Resource Officer, Global |
R. Todd Joyce |
55 | 2012 | Chief Financial Officer, Global |
Charles Mayr |
56 | 2012 | Chief Communication Officer, Global |
Christopher Bodine |
57 | 2009 | Independent Director |
Michael Fedida |
66 | 1995 | Independent Director |
Michel Feldman |
70 | 2002 | Independent Director |
Albert Hummel |
68 | 1991 | Independent Director |
Catherine Klema |
54 | 2004 | Independent Director |
Jack Michelson |
78 | 2002 | Independent Director |
Ronald Taylor |
65 | 1994 | Independent Director |
Fred Weiss |
71 | 2000 | Independent Director |
Lisa DeFrancesco |
VP, Global Investor Relations |

